NEW YORK (GenomeWeb News) – Accelr8 Technology and integrated healthcare provider Denver Health have received a $2 million award from the Defense Medical Research and Development Program to develop diagnostic products for antibiotic-resistant infections.
Accelr8 said today that the collaboration will apply the firm's BACcel system to wound infections and other serious infections secondary to trauma. It said that the joint project was the sole recipient under the Military Infectious Diseases Applied Research Award program for rapid detection of serious antibiotic-resistant infections.
In addition to Accelr8 and Denver Health, other collaborators in the effort include the Department of Veterans Affairs Eastern Colorado Healthcare System, the Washington Hospital Center, and Creighton University School of Medicine.